A review of addiction

Area of Science:

• Neuroscience
• Addiction Medicine
• Psychiatry

Background:

• Substance addiction is frequently undiagnosed and untreated, often due to physician unawareness or negative attitudes.
• Addiction is characterized by compulsive substance use despite negative consequences, involving altered neurological reward and decision-making pathways.
• Genetic predispositions and developmental brain abnormalities can increase an individual's susceptibility to addiction.

Purpose of the Study:

• To elucidate the neurological underpinnings of addiction, focusing on the mesolimbic dopamine reward pathway and the prefrontal cortex.
• To highlight the biological basis of addiction as a treatable brain disease.
• To emphasize the critical role of physicians in the prevention, diagnosis, and treatment of addiction.

Main Methods:

• Review of current understanding of neurological pathways involved in addiction (mesolimbic dopamine reward pathway, prefrontal cortex).
• Discussion of factors contributing to addiction, including genetic and developmental influences.
• Examination of available and emerging pharmacological and cognitive-behavioral treatment interventions.

Main Results:

• Drug abuse physically alters the mesolimbic dopamine reward pathway, leading to uncontrolled cravings.
• Abuse also affects the prefrontal cortex, impairing the ability to suppress reward responses, resulting in compulsive use.
• Individualized treatments, combining pharmacological and cognitive-behavioral approaches, show success comparable to other chronic diseases.

Conclusions:

• Addiction is a chronic brain disease with identifiable neurological mechanisms, not a moral failing.
• Effective pharmacological and cognitive-behavioral treatments are available, necessitating physician optimism and active involvement.
• Physicians play a vital role in addressing addiction through comprehensive care, including prevention, diagnosis, intervention, and follow-up.